OxHDL controls LOX-1 expression and plasma membrane localization through a mechanism dependent on NOX/ROS/NF-κB pathway on endothelial cells
dc.contributor.author | Pérez, Lorena | |
dc.contributor.author | Vallejos, Alejandro | |
dc.contributor.author | Echeverria, Cesar | |
dc.contributor.author | Varela, Diego | |
dc.contributor.author | Cabello-Verrugio, Claudio | |
dc.contributor.author | Simon, Felipe | |
dc.date.accessioned | 2024-07-02T19:06:32Z | |
dc.date.available | 2024-07-02T19:06:32Z | |
dc.date.issued | 2019-03-01 | |
dc.description | Indexación: Scopus. | |
dc.description.abstract | Systemic inflammatory diseases enhance circulating oxidative stress levels, which results in the oxidation of circulating high-density lipoprotein (oxHDL). Endothelial cell function can be negatively impacted by oxHDL, but the underlying mechanisms for this remain unclear. Some reports indicate that the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is also a receptor for oxHDL. However, it is unknown if oxHDL induces increased LOX-1 expression at the plasma membrane, as an event that supports endothelial dysfunction. Therefore, the aims of this study were to determine if oxHDL induces plasma-membrane level changes in LOX-1 and, if so, to describe the underlying mechanisms in endothelial cells. Our results demonstrate that the incubation of arterial or vein endothelial cells with oxHDL (and not HDL) induces the increase of LOX-1 expression at the plasma membrane; effect prevented by LOX-1 inhibition. Importantly, same results were observed in endothelial cells from oxHDL-treated rats. Furthermore, the observed oxHDL-induced LOX-1 expression is abolished by the down-regulation of NOX-2 expression with siRNA (and no others NOX isoforms), by the pharmacological inhibition of NAD(P)H oxidase (with DPI or apocynin) or by the inhibition of NF-κB transcription factor. Coherently, LOX-1 expression is augmented by the incubation of endothelial cells with H2O2 or GSSG even in absence of oxHDL, indicating that the NOX-2/ROS/ NF-κB axis is involved. Interestingly, oxHDL incubation also increases TNF-α expression, cytokine that induces LOX-1 expression. Thus, our results suggest a positive feedback mechanism for LOX-1 receptor during inflammatory condition where an oxidative burst will generate oxHDL from native HDL, activating LOX-1 receptor which in turn will increase the expression of NOX-2, TNF-α and LOX-1 receptor at the plasma membrane. In conclusion, oxHDL-induced translocation of LOX-1 to the plasma membrane could constitute an induction mechanism of endothelial dysfunction in systemic inflammatory diseases. | |
dc.description.uri | https://www.nature.com/articles/s41374-018-0151-3.pdf | |
dc.identifier.citation | Laboratory Investigation Volume 99, Issue 3, Pages 421 - 437 1 March 2019 | |
dc.identifier.doi | 10.1038/s41374-018-0151-3 | |
dc.identifier.issn | 0023-6837 | |
dc.identifier.uri | https://repositorio.unab.cl/handle/ria/58168 | |
dc.language.iso | en_US | |
dc.publisher | Nature Publishing Group | |
dc.rights.license | ATRIBUCIÓN-NOCOMERCIAL-SINDERIVADAS 4.0 INTERNACIONAL | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.es | |
dc.subject | Animals | |
dc.subject | Cell Membrane | |
dc.subject | Cells, Cultured | |
dc.subject | Endothelial Cells | |
dc.subject | Human Umbilical Vein Endothelial Cells | |
dc.subject | Humans | |
dc.subject | Inflammation | |
dc.subject | Lipoproteins, HDL | |
dc.subject | Male | |
dc.subject | NADPH Oxidase 2 | |
dc.subject | NF-kappa B | |
dc.subject | Oxidation-Reduction | |
dc.subject | Oxidative Stress | |
dc.subject | Rats | |
dc.subject | Rats, Sprague-Dawley | |
dc.subject | Reactive Oxygen Species | |
dc.subject | Scavenger Receptors, Class E | |
dc.subject | Signal Transduction | |
dc.title | OxHDL controls LOX-1 expression and plasma membrane localization through a mechanism dependent on NOX/ROS/NF-κB pathway on endothelial cells | |
dc.type | Artículo |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- s41374-018-0151-3.pdf
- Tamaño:
- 3.43 MB
- Formato:
- Adobe Portable Document Format
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: